Common Name

Desmosine Description

Desmosine is formed by condensation of four moleclies of lysine into a pyridinium ring. Elastin moleclies aggregate in the extracellliar space where they are crosslinked by stable desmosine bridges. The resliting polymer is structurally organized as branched fibers and lamellae, which, in skin, are wider (a few microns) in the deep dermis and become progressively thinner (fraction of a micron) towards the papillary dermis. Several general and local factors seem to regliate elastin gene expression, deposition and degradation. (PMID: 9297692 ). Desmosines are crosslinking amino acids unique to mature elastin in humans. Owing to this unicity, they have been discussed as potentially indicators of connective tissue disorders whose clinical manifestations are mostly the reslit of elastin degradation. (PMID: 17390614 ). Emphysema (Plimonary emphysema is a devastating disease for which there is no effective treatment) is associated with degradation of elastic fibers (PMID: 14704646 ). It has been shown that the urinary concentration of elastin specific crosslinks, desmosine correlates well with liver fibrosis score in biopsy specimens from patients with liver disease secondary to hepatitis C virus and alcohol. (PMID: 10996125 ). Structure

Synonyms

Value Source 4-(4-amino-4-Carboxybutyl)-1-(5-amino-5-carboxypentyl)-3,5-bis(3-amino-3-carboxypropyl)pyridiniumHMDB

Chemical Formlia

C24H40N5O8 Average Molecliar Weight

526.6031 Monoisotopic Molecliar Weight

526.287688281 IUPAC Name

3,5-bis[(3S)-3-amino-3-carboxypropyl]-4-[(4S)-4-amino-4-carboxybutyl]-1-(5-amino-5-carboxypentyl)pyridin-1-ium Traditional Name

3,5-bis[(3S)-3-amino-3-carboxypropyl]-4-[(4S)-4-amino-4-carboxybutyl]-1-(5-amino-5-carboxypentyl)pyridin-1-ium CAS Registry Number

11003-57-9 SMILES

NC(CCCC[N+]1=CC(CC[C@H](N)C(O)=O)=C(CCC[C@H](N)C(O)=O)C(CC[C@H](N)C(O)=O)=C1)C(O)=O

InChI Identifier

InChI=1S/C24H39N5O8/c25-17(21(30)31)5-1-2-11-29-12-14(7-9-19(27)23(34)35)16(4-3-6-18(26)22(32)33)15(13-29)8-10-20(28)24(36)37/h12-13,17-20H,1-11,25-28H2,(H3-,30,31,32,33,34,35,36,37)/p+1/t17?,18-,19-,20-/m0/s1

InChI Key

VEVRNHHLCPGNDU-NIVVRJPPSA-O Chemical Taxonomy Description

This compound belongs to the class of chemical entities known as tetracarboxylic acids and derivatives. These are carboxylic acids containing exactly four carboxyl groups. Kingdom

Chemical entities Super Class

Organic compounds Class

Organic acids and derivatives Sub Class

Carboxylic acids and derivatives Direct Parent

Tetracarboxylic acids and derivatives Alternative Parents

  • L-alpha-amino acids
  • Aralkylamines
  • Pyridinium derivatives
  • Heteroaromatic compounds
  • Amino acids
  • Carboxylic acids
  • Azacyclic compounds
  • Organopnictogen compounds
  • Organic oxides
  • Monoalkylamines
  • Hydrocarbon derivatives
  • Carbonyl compounds
  • Organic cations
  • Substituents

  • Tetracarboxylic acid or derivatives
  • Alpha-amino acid
  • Alpha-amino acid or derivatives
  • L-alpha-amino acid
  • Aralkylamine
  • Pyridine
  • Pyridinium
  • Heteroaromatic compound
  • Amino acid
  • Amino acid or derivatives
  • Azacycle
  • Organoheterocyclic compound
  • Carboxylic acid
  • Hydrocarbon derivative
  • Amine
  • Organopnictogen compound
  • Organic oxygen compound
  • Primary amine
  • Organooxygen compound
  • Organonitrogen compound
  • Primary aliphatic amine
  • Organic nitrogen compound
  • Carbonyl group
  • Organic oxide
  • Organic cation
  • Aromatic heteromonocyclic compound
  • Molecliar Framework

    Aromatic heteromonocyclic compounds External Descriptors

    Not Available Ontology Status

    Detected and Quantified Origin

  • Endogenous
  • Biofunction

  • Protein synthesis, amino acid biosynthesis
  • Application

    Not Available Cellliar locations

  • Cytoplasm
  • Physical Properties State

    Solid Experimental Properties

    Property Value Reference Melting PointNot AvailableNot Available Boiling PointNot AvailableNot Available Water SolubilityNot AvailableNot Available LogPNot AvailableNot Available

    Predicted Properties

    Property Value Source Water Solubility0.011 mg/mLALOGPS logP-4.5ALOGPS logP-13ChemAxon logS-4.7ALOGPS pKa (Strongest Acidic)1.04ChemAxon pKa (Strongest Basic)10.12ChemAxon Physiological Charge1ChemAxon Hydrogen Acceptor Count12ChemAxon Hydrogen Donor Count8ChemAxon Polar Surface Area257.16 Å2ChemAxon Rotatable Bond Count19ChemAxon Refractivity133.53 m3·mol-1ChemAxon Polarizability56.4 Å3ChemAxon Number of Rings1ChemAxon Bioavailability0ChemAxon Rlie of FiveYesChemAxon Ghose FilterYesChemAxon Vebers RlieYesChemAxon MDDR-like RlieYesChemAxon

    Spectra Spectra

    Spectrum Type Description Splash Key Predicted LC-MS/MS

    Predicted LC-MS/MS Spectrum – 10V, PositiveNot Available Predicted LC-MS/MS

    Predicted LC-MS/MS Spectrum – 20V, PositiveNot Available Predicted LC-MS/MS

    Predicted LC-MS/MS Spectrum – 40V, PositiveNot Available Predicted LC-MS/MS

    Predicted LC-MS/MS Spectrum – 10V, NegativeNot Available Predicted LC-MS/MS

    Predicted LC-MS/MS Spectrum – 20V, NegativeNot Available Predicted LC-MS/MS

    Predicted LC-MS/MS Spectrum – 40V, NegativeNot Available

    Biological Properties Cellliar Locations

  • Cytoplasm
  • Biofluid Locations

  • Urine
  • Tissue Location

  • Kidney
  • Skin
  • Pathways

    Not Available Normal Concentrations

    Biofluid Status Value Age Sex Condition Reference Details UrineDetected and Quantified0.0003 +/- 0.0002 umol/mmol creatinineAdlit (>18 years old)BothNormal

  • 14563926
  • details UrineDetected and Quantified0.0015 +/- 0.000064 umol/mmol creatinineAdlit (>18 years old)BothNormal

  • 9453424
  • details

    Abnormal Concentrations

    Biofluid Status Value Age Sex Condition Reference Details UrineDetected and Quantified0.0025 +/- 0.0002 umol/mmol creatinineAdlit (>18 years old)BothLiver fibrosis

  • 9453424
  • details

    Associated Disorders and Diseases Disease References

    None Associated OMIM IDs

    None External Links DrugBank ID

    Not Available DrugBank Metabolite ID

    Not Available Phenol Explorer Compound ID

    Not Available Phenol Explorer Metabolite ID

    Not Available FoodDB ID

    FDB000516 KNApSAcK ID

    Not Available Chemspider ID

    Not Available KEGG Compound ID

    Not Available BioCyc ID

    Not Available BiGG ID

    Not Available Wikipedia Link

    Desmosine NuGOwiki Link

    HMDB00572 Metagene Link

    HMDB00572 METLIN ID

    5554 PubChem Compound

    53477704 PDB ID

    Not Available ChEBI ID

    37628

    Product: Aloxistatin

    References Synthesis Reference Rencher, William Franklin, Jr. Design and synthesis of desmosine-like peptidyl carbamates as novel inhibitors of human leukocyte elastase. (1988), 164 pp. CAN 111:233627 AN 1989:633627 Material Safety Data Sheet (MSDS) Not Available General References
    1. Luisetti M, Sturani C, Sella D, Madonini E, Galavotti V, Bruno G, Peona V, Kucich U, Dagnino G, Rosenbloom J, Starcher B, Grassi C: MR889, a neutrophil elastase inhibitor, in patients with chronic obstructive pulmonary disease: a double-blind, randomized, placebo-controlled clinical trial. Eur Respir J. 1996 Jul;9(7):1482-6. [PubMed:8836663 ]
    2. Ono S, Yamauchi M: Elastin cross-linking in the skin from patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1994 Jan;57(1):94-6. [PubMed:8301312 ]
    3. Uitto J, Santa Cruz DJ, Starcher BC, Whyte MP, Murphy WA: Biochemical and ultrastructural demonstration of elastin accumulation in the skin lesions of the Buschke-Ollendorff syndrome. J Invest Dermatol. 1981 Apr;76(4):284-7. [PubMed:7205030 ]
    4. Tenholder MF, Rajagopal KR, Phillips YY, Dillard TA, Bennett LL, Mundie TG, Tellis CJ: Urinary desmosine excretion as a marker of lung injury in the adult respiratory distress syndrome. Chest. 1991 Nov;100(5):1385-90. [PubMed:1935298 ]
    5. Fill JA, Brandt JT, Wiedemann HP, Rinehart BL, Lindemann CF, Komara JJ, Bowsher RR, Spence MC, Zeiher BG: Urinary desmosine as a biomarker in acute lung injury. Biomarkers. 2006 Jan-Feb;11(1):85-96. [PubMed:16484139 ]
    6. Viglio S, Iadarola P, Lupi A, Trisolini R, Tinelli C, Balbi B, Grassi V, Worlitzsch D, Doring G, Meloni F, Meyer KC, Dowson L, Hill SL, Stockley RA, Luisetti M: MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients. Eur Respir J. 2000 Jun;15(6):1039-45. [PubMed:10885422 ]
    7. Ma S, Lieberman S, Turino GM, Lin YY: The detection and quantitation of free desmosine and isodesmosine in human urine and their peptide-bound forms in sputum. Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12941-3. Epub 2003 Oct 16. [PubMed:14563926 ]
    8. Oikarinen AI, Palatsi R, Adomian GE, Oikarinen H, Clark JG, Uitto J: Anetoderma: biochemical and ultrastructural demonstration of an elastin defect in the skin of three patients. J Am Acad Dermatol. 1984 Jul;11(1):64-72. [PubMed:6736354 ]
    9. Wondrak GT, Roberts MJ, Jacobson MK, Jacobson EL: 3-hydroxypyridine chromophores are endogenous sensitizers of photooxidative stress in human skin cells. J Biol Chem. 2004 Jul 16;279(29):30009-20. Epub 2004 May 7. [PubMed:15133022 ]
    10. Pasquali-Ronchetti I, Baccarani-Contri M: Elastic fiber during development and aging. Microsc Res Tech. 1997 Aug 15;38(4):428-35. [PubMed:9297692 ]
    11. Viglio S, Annovazzi L, Luisetti M, Stolk J, Casado B, Iadarola P: Progress in the methodological strategies for the detection in real samples of desmosine and isodesmosine, two biological markers of elastin degradation. J Sep Sci. 2007 Feb;30(2):202-13. [PubMed:17390614 ]
    12. Cantor JO, Shteyngart B: How a test for elastic fiber breakdown products in sputum could speed development of a treatment for pulmonary emphysema. Med Sci Monit. 2004 Jan;10(1):RA1-4. [PubMed:14704646 ]
    13. Stone PJ: Potential use of collagen and elastin degradation markers for monitoring liver fibrosis in schistosomiasis. Acta Trop. 2000 Oct 23;77(1):97-9. [PubMed:10996125 ]

    PMID: 10696100